Your browser doesn't support javascript.
Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021.
Acosta, Anna M; Garg, Shikha; Pham, Huong; Whitaker, Michael; Anglin, Onika; O'Halloran, Alissa; Milucky, Jennifer; Patel, Kadam; Taylor, Christopher; Wortham, Jonathan; Chai, Shua J; Kirley, Pam Daily; Alden, Nisha B; Kawasaki, Breanna; Meek, James; Yousey-Hindes, Kimberly; Anderson, Evan J; Openo, Kyle P; Weigel, Andrew; Monroe, Maya L; Ryan, Patricia; Reeg, Libby; Kohrman, Alexander; Lynfield, Ruth; Bye, Erica; Torres, Salina; Salazar-Sanchez, Yadira; Muse, Alison; Barney, Grant; Bennett, Nancy M; Bushey, Sophrena; Billing, Laurie; Shiltz, Eli; Sutton, Melissa; Abdullah, Nasreen; Talbot, H Keipp; Schaffner, William; Ortega, Jake; Price, Andrea; Fry, Alicia M; Hall, Aron; Kim, Lindsay; Havers, Fiona P.
  • Acosta AM; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Garg S; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Pham H; US Public Health Service, Rockville, Maryland.
  • Whitaker M; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Anglin O; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • O'Halloran A; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Milucky J; General Dynamics Information Technology, Atlanta, Georgia.
  • Patel K; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Taylor C; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Wortham J; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Chai SJ; General Dynamics Information Technology, Atlanta, Georgia.
  • Kirley PD; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Alden NB; COVID-19-Associated Hospitalization Surveillance Network, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kawasaki B; US Public Health Service, Rockville, Maryland.
  • Meek J; California Emerging Infections Program, Oakland.
  • Yousey-Hindes K; Career Epidemiology Field Officer, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Anderson EJ; California Emerging Infections Program, Oakland.
  • Openo KP; Colorado Department of Public Health and Environment, Denver.
  • Weigel A; Colorado Department of Public Health and Environment, Denver.
  • Monroe ML; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven.
  • Ryan P; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven.
  • Reeg L; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
  • Kohrman A; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Lynfield R; Georgia Emerging Infections Program, Georgia Department of Health, Atlanta.
  • Bye E; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
  • Torres S; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Salazar-Sanchez Y; Georgia Emerging Infections Program, Georgia Department of Health, Atlanta.
  • Muse A; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
  • Barney G; Iowa Department of Public Health, Des Moines.
  • Bennett NM; Maryland Department of Health, Baltimore.
  • Bushey S; Maryland Department of Health, Baltimore.
  • Billing L; Michigan Department of Health and Human Services, Lansing.
  • Shiltz E; Michigan Department of Health and Human Services, Lansing.
  • Sutton M; Minnesota Department of Health, St Paul.
  • Abdullah N; Minnesota Department of Health, St Paul.
  • Talbot HK; New Mexico Department of Health, Santa Fe.
  • Schaffner W; New Mexico Department of Health, Santa Fe.
  • Ortega J; New York State Department of Health, Albany.
  • Price A; New York State Department of Health, Albany.
  • Fry AM; University of Rochester School of Medicine and Dentistry, Rochester, New York.
  • Hall A; University of Rochester School of Medicine and Dentistry, Rochester, New York.
  • Kim L; Ohio Department of Health, Columbus.
  • Havers FP; Ohio Department of Health, Columbus.
JAMA Netw Open ; 4(10): e2130479, 2021 10 01.
Article in English | MEDLINE | ID: covidwho-1482074
ABSTRACT
Importance Racial and ethnic minority groups are disproportionately affected by COVID-19.

Objectives:

To evaluate whether rates of severe COVID-19, defined as hospitalization, intensive care unit (ICU) admission, or in-hospital death, are higher among racial and ethnic minority groups compared with non-Hispanic White persons. Design, Setting, and

Participants:

This cross-sectional study included 99 counties within 14 US states participating in the COVID-19-Associated Hospitalization Surveillance Network. Participants were persons of all ages hospitalized with COVID-19 from March 1, 2020, to February 28, 2021. Exposures Laboratory-confirmed COVID-19-associated hospitalization, defined as a positive SARS-CoV-2 test within 14 days prior to or during hospitalization. Main Outcomes and

Measures:

Cumulative age-adjusted rates (per 100 000 population) of hospitalization, ICU admission, and death by race and ethnicity. Rate ratios (RR) were calculated for each racial and ethnic group compared with White persons.

Results:

Among 153 692 patients with COVID-19-associated hospitalizations, 143 342 (93.3%) with information on race and ethnicity were included in the analysis. Of these, 105 421 (73.5%) were 50 years or older, 72 159 (50.3%) were male, 28 762 (20.1%) were Hispanic or Latino, 2056 (1.4%) were non-Hispanic American Indian or Alaska Native, 7737 (5.4%) were non-Hispanic Asian or Pacific Islander, 40 806 (28.5%) were non-Hispanic Black, and 63 981 (44.6%) were White. Compared with White persons, American Indian or Alaska Native, Latino, Black, and Asian or Pacific Islander persons were more likely to have higher cumulative age-adjusted rates of hospitalization, ICU admission, and death as follows American Indian or Alaska Native (hospitalization RR, 3.70; 95% CI, 3.54-3.87; ICU admission RR, 6.49; 95% CI, 6.01-7.01; death RR, 7.19; 95% CI, 6.47-7.99); Latino (hospitalization RR, 3.06; 95% CI, 3.01-3.10; ICU admission RR, 4.20; 95% CI, 4.08-4.33; death RR, 3.85; 95% CI, 3.68-4.01); Black (hospitalization RR, 2.85; 95% CI, 2.81-2.89; ICU admission RR, 3.17; 95% CI, 3.09-3.26; death RR, 2.58; 95% CI, 2.48-2.69); and Asian or Pacific Islander (hospitalization RR, 1.03; 95% CI, 1.01-1.06; ICU admission RR, 1.91; 95% CI, 1.83-1.98; death RR, 1.64; 95% CI, 1.55-1.74). Conclusions and Relevance In this cross-sectional analysis, American Indian or Alaska Native, Latino, Black, and Asian or Pacific Islander persons were more likely than White persons to have a COVID-19-associated hospitalization, ICU admission, or in-hospital death during the first year of the US COVID-19 pandemic. Equitable access to COVID-19 preventive measures, including vaccination, is needed to minimize the gap in racial and ethnic disparities of severe COVID-19.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hospital Mortality / Health Status Disparities / COVID-19 / Hospitalization / Intensive Care Units Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article Affiliation country: Jamanetworkopen.2021.30479

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Hospital Mortality / Health Status Disparities / COVID-19 / Hospitalization / Intensive Care Units Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article Affiliation country: Jamanetworkopen.2021.30479